-
My Account
My Account
BSE Live
Jan 19, 16:00Prev. Close
171.05
Open Price
171.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 19, 15:47Prev. Close
171.00
Open Price
174.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
169.65 (31)
| Balance Sheet of Venus Remedies (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 12.34 | 12.34 | 12.34 | 12.34 | 11.44 | |
| Total Share Capital | 12.34 | 12.34 | 12.34 | 12.34 | 11.44 | |
| Reserves and Surplus | 319.91 | 328.61 | 355.65 | 381.89 | 432.99 | |
| Total Reserves and Surplus | 319.91 | 328.61 | 355.65 | 381.89 | 432.99 | |
| Total Shareholders Funds | 332.25 | 340.95 | 367.99 | 394.23 | 444.43 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 72.26 | 116.08 | 136.86 | 161.82 | 191.03 | |
| Deferred Tax Liabilities [Net] | 16.85 | 14.88 | 16.03 | 12.87 | 16.59 | |
| Other Long Term Liabilities | 0.29 | 0.45 | 0.50 | 0.54 | 0.63 | |
| Long Term Provisions | 6.63 | 5.32 | 4.50 | 4.29 | 3.79 | |
| Total Non-Current Liabilities | 96.03 | 136.75 | 157.89 | 179.52 | 212.03 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 81.42 | 108.92 | 117.23 | 115.70 | 115.09 | |
| Trade Payables | 33.96 | 33.41 | 27.19 | 30.56 | 23.90 | |
| Other Current Liabilities | 93.94 | 107.61 | 76.87 | 45.70 | 36.63 | |
| Short Term Provisions | 0.61 | 4.52 | 1.32 | 1.76 | 1.97 | |
| Total Current Liabilities | 209.93 | 254.46 | 222.61 | 193.71 | 177.59 | |
| Total Capital And Liabilities | 638.21 | 732.16 | 748.49 | 767.47 | 834.05 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 167.41 | 180.16 | 190.62 | 197.51 | 194.10 | |
| Intangible Assets | 104.06 | 166.73 | 179.30 | 191.88 | 239.43 | |
| Capital Work-In-Progress | 24.63 | 64.76 | 64.76 | 66.25 | 70.76 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 296.10 | 411.65 | 434.69 | 455.63 | 513.89 | |
| Non-Current Investments | 0.14 | 0.14 | 0.14 | 28.74 | 28.74 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 32.90 | |
| Other Non-Current Assets | 64.08 | 66.78 | 65.13 | 33.17 | 0.00 | |
| Total Non-Current Assets | 360.33 | 478.57 | 499.96 | 517.54 | 575.53 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 136.44 | 140.94 | 135.98 | 139.69 | 137.69 | |
| Trade Receivables | 29.78 | 31.39 | 44.15 | 41.91 | 53.88 | |
| Cash And Cash Equivalents | 1.44 | 1.28 | 3.64 | 3.15 | 3.04 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 63.91 | |
| OtherCurrentAssets | 110.23 | 79.98 | 64.77 | 65.18 | 0.00 | |
| Total Current Assets | 277.89 | 253.59 | 248.53 | 249.93 | 258.53 | |
| Total Assets | 638.21 | 732.16 | 748.49 | 767.47 | 834.05 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.21 | 2.53 | 1.77 | 2.27 | 2.09 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 73.63 | 85.83 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.14 | 0.14 | 0.14 | 28.74 | 28.74 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
04.12.2020
Venus Remedies Standalone September 2020 Net Sales at Rs 118.41 crore, up 47.86% Y-o-Y
18.02.2019
Venus Remedies Standalone December 2018 Net Sales at Rs 69.06 crore, down 25.84% Y-o-Y
15.11.2018
Venus Remedies Standalone September 2018 Net Sales at Rs 80.89 crore, down 10.63% Y-o-Y
03.04.2017
04.12.2020
Venus Remedies Standalone September 2020 Net Sales at Rs 118.41 crore, up 47.86% Y-o-Y
18.02.2019
Venus Remedies Standalone December 2018 Net Sales at Rs 69.06 crore, down 25.84% Y-o-Y
15.11.2018
Venus Remedies Standalone September 2018 Net Sales at Rs 80.89 crore, down 10.63% Y-o-Y
13.02.2014
